Cytokine activin C ameliorates chronic neuropathic pain in peripheral nerve injury rodents by modulating the TRPV1 channel
Ya‐Kun Huang,Yu‐Gang Lu,Xin Zhao,Jing‐Bing Zhang,Feng‐Ming Zhang,Yong Chen,Ling‐Bo Bi,Jia‐Hui Gu,Zuo‐Jie Jiang,Xiao‐Man Wu,Qing‐Yi Li,Yanli Liu,Jian‐Xin Shen,Xing‐Jun Liu
DOI: https://doi.org/10.1111/bph.15284
IF: 7.3
2020-11-16
British Journal of Pharmacology
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background and Purpose</h3><p>Reportedly, cytokine activin C is mainly expressed in small‐diameter dorsal root ganglion (DRG) neurons and suppresses inflammatory pain. However, the effects of activin C in neuropathic pain remain elusive.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Experimental Approach</h3><p>Male rats, as well as wild type and transient receptor potential cation channel (TRP)V1 knockout mice, underwent peripheral nerve injury to establish chronic neuropathic pain. Ipsilateral lumbar (L)4~5 DRGs were assayed for activin C expression. Chronic neuropathic pain rat and mouse models were administered intrathecal or locally pre‐administered activin C or the vehicle; then, nociceptive behaviors and pain‐related markers in L4~5 DRGs and spinal cord were evaluated, and TRPV1 modulation by activin C was measured.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Key Results</h3><p>Following peripheral nerve injury, the expression of activin βC subunit mRNA and activin C protein was markedly upregulated in L4~5 DRGs of experimental animals. Intrathecal activin C dose‐dependently inhibited neuropathic pain in spinal nerve ligated rats. Local pre‐administration of activin C decreased neuropathic pain, macrophage infiltration into ipsilateral L4~5 DRGs, and microglial reaction in L4~5 spinal cords of chronic constriction injury (CCI) mice. In rat DRG neurons, activin C enhanced capsaicin‐induced TRPV1 currents. Pre‐administration of activin C reduced capsaicin‐evoked acute hyperalgesia and normalized capsaicin‐evoked persistent hypothermia in mice. Finally, the analgesic effect of activin C was abolished in TRPV1 knockout mice following CCI.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion and Implications</h3><p>Activin C functions as an inhibitory regulator of neuropathic pain by modulating TRPV1 channels, revealing potential analgesic applications in chronic neuropathic pain therapy.</p></section>
pharmacology & pharmacy